Hays Advisory’s Gilead Sciences GILD Stock Holding History

Hays Advisory’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-18,503	Closed	-$1.43M	–	23
2018 Q3	$1.43M	Sell	18,503 -362	-2%	-$27.3K	0.91%	33
2018 Q2	$1.34M	Sell	18,865 -1,409	-7%	-$99.5K	0.74%	35
2018 Q1	$1.53M	Sell	20,274 -8,956	-31%	-$712K	0.74%	36
2017 Q4	$2.09M	Sell	29,230 -10,842	-27%	-$823K	0.74%	38
2017 Q3	$3.25M	Sell	40,072 -3,099	-7%	-$237K	0.94%	32
2017 Q2	$3.06M	Sell	43,171 -4,831	-10%	-$321K	0.75%	37
2017 Q1	$3.26M	Sell	48,002 -1,803	-4%	-$127K	0.77%	38
2016 Q4	$3.57M	Sell	49,805 -15,325	-24%	-$1.14M	0.8%	35
2016 Q3	$5.15M	Sell	65,130 -6,907	-10%	-$561K	0.86%	28
2016 Q2	$6.01M	Sell	72,037 -11,842	-14%	-$1.05M	0.93%	27
2016 Q1	$7.71M	Sell	83,879 -11,250	-12%	-$1.01M	1.08%	25
2015 Q4	$9.63M	Sell	95,129 -8,520	-8%	-$887K	1.63%	15
2015 Q3	$10.2M	Sell	103,649 -656	-0.6%	-$72.9K	1.54%	21
2015 Q2	$12.2M	Sell	104,305 -8,005	-7%	-$875K	1.77%	16
2015 Q1	$11M	Buy	+112,310	New	+$11.4M	1.42%	30

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Hays Advisory's GILD Position: Q4 2018 in Review

Hays Advisory sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 18,503 shares — an estimated $1.43M sold.

Hays Advisory first reported a position in GILD in Q1 2015 and held it in 15 quarters. The position peaked at $12.2M in Q2 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

Hays Advisory reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
Hays Advisory sold 18,503 Gilead Sciences shares in Q4 2018, an estimated $1.43M.
Hays Advisory first reported a position in Gilead Sciences in Q1 2015 and held it in 15 quarters.
Hays Advisory's Gilead Sciences position peaked at $12.2M in Q2 2015.
1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Hays Advisory's 13F filing for Q4 2018.